Latest Low-density lipoprotein Stories
New Studies Provide More Evidence that Daily Consumption of Strawberries Can Have Positive Impact on Health WATSONVILLE, Calif., April 1, 2015 /PRNewswire-USNewswire/ -- Two new studies presented
Submission of Application in Japan Marks an Important Milestone in Strategic Partnership With Amgen Astellas BioPharma THOUSAND OAKS, Calif., March 20, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN)
- Robust and consistent LDL-C lowering demonstrated with Praluent(TM) in largest, double-blind, placebo-controlled trial of a PCSK9 inhibitor to date - PARIS and TARRYTOWN, N.Y., March 15,
Analysis From Prespecified Exploratory Endpoints Presented in Late-Breaking Session at ACC.15 Showed Repatha Plus Standard of Care Lowered Cardiovascular Events THOUSAND OAKS, Calif., March
Data From PCSK9 Inhibitor Study Support Regulatory Filing in Japan THOUSAND OAKS, Calif., March 14, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new detailed data from the Phase
Emerald Logic FACET software generates predictive models and identifies novel variables driving RVX-208 drug efficacy, safety and reduced MACE incidence TSX Exchange Symbol: RVX
Data Evaluating the Effect of Repatha(TM)(Evolocumab) on LDL-C and Cardiovascular Events to be Featured in Late-Breaking Session THOUSAND OAKS, Calif., March 2, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN)
Congressional briefing highlights results of national patient research indicating the need to improve medication adherence, access to medication and enrollment of women in clinical trials, policy recommendations
Proper cholesterol management can make the difference between a full active lifestyle and one plagued with avoidable health problems.
- A young boy, a servant boy; a lackey.